IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat

Thomas K. Sears*, Craig M. Horbinski, Kevin D. Woolard

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat'. Together they form a unique fingerprint.

Medicine & Life Sciences